Get the Stockscreener App
8.18
9.72%
0.98
Moolec Science Sa stock is traded at $8.18, with a volume of 15,386.
It is up +9.72% in the last 24 hours and up +20.79% over the past month.
Moolec Science SA is a science-based ingredient company focused on producing real animal proteins in plants through Molecular Farming, a technology in the alternative protein landscape. Its purpose is to upgrade the taste, nutrition, and affordability of alternative protein products while building a more sustainable and equitable food system. The company has various products in its pipeline, such as; TSP Valorasoy which is a soy protein product to produce vegetable proteins with texture and fibrousness similar to those of meat, Glaso, a safflower oil with high levels of gamma-linolenic acid, SPC2 which is a plant-based chymosin, YEEA1, an extract derived from a novel yeast biomass with specific properties, and others. The company's maximum revenues from operations in Argentina.
See More
Previous Close:
$7.20
Open:
$7
24h Volume:
15,386
Relative Volume:
0.92
Market Cap:
$5.80M
Revenue:
$7.83M
Net Income/Loss:
$-8.28M
P/E Ratio:
-0.4847
EPS:
-16.8761
Net Cash Flow:
$-6.85M
1W Performance:
+12.75%
1M Performance:
+20.79%
6M Performance:
-17.54%
1Y Performance:
-78.60%
1-Day Range:
$6.7102
$8.00
1-Week Range:
$6.64
$7.87
52-Week Range:
$3.0765
$38.55
Moolec Science Sa Stock (MLEC) Company Profile
Compare MLEC vs VRTX, REGN, ARGX, RVMD, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MLEC
Moolec Science Sa
|
8.00 | 5.22M | 7.83M | -8.28M | -6.85M | -16.88 |
VRTX
Vertex Pharmaceuticals Inc
|
515.90 | 128.19B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
807.13 | 82.72B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
991.63 | 53.26B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
213.72 | 43.66B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
362.63 | 39.31B | 5.76B | 514.49M | 1.10B | 4.4813 |
Moolec Science Sa Stock (MLEC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-27-23 | Initiated | ROTH MKM | Buy |
Moolec Science Sa Stock (MLEC) Latest News
Moolec Science (MLEC) Edges Higher, Holds Above Key Support at $7.20Cup and Handle - dars.gov.et
Why Did This Nano-Cap Food Stock More Than Double In Value Today? - Stocktwits
Moolec Science SA Warrants (MLECW) Live Share Price, Invest From India - INDmoney
Moolec Science SA (MLEC) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Moolec Science (MLEC) Slides Marginally as Shares Approach Key Support at $6.84Channel Projection - dars.gov.et
Moolec Science SA Revenue Breakdown – NASDAQ:MLEC - TradingView
Moolec Science SA (MLEC) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Moolec Science SA (MLEC) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Moolec Science SA (MLEC) Institutional Confidence - TradingKey
Moolec Science SA (MLEC) Cash Flow - TradingKey
MLEC|Moolec Science SA|Price:8.600|Chg%:+1.237 - TradingKey
Moolec Science SA (MLEC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Moolec Science SA (MLEC) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
MLEC|Moolec Science SA|Price:7.330|Chg%:+0.140 - TradingKey
Moolec Science SA (MLEC) Income Statement - tradingkey.com
Moolec Science SA Revenue Breakdown – NASDAQ:MLECW - TradingView
Moolec Science SA (MLEC) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Moolec Science SA (MLEC) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Price to earnings forward of Moolec Science SA – NASDAQ:MLECW - TradingView
Moolec Science Faces Cayman Winding Up Petition Over Disputed Legal Fees - The Globe and Mail
[6-K] Moolec Science SA Current Report (Foreign Issuer) - Stock Titan
12 Consumer Staples Stocks Moving In Friday's Intraday Session - Sahm
MLEC Q2 2025 Earnings: Narrower-than-expected loss amid pre‑revenue stageNew Analyst Coverage - dars.gov.et
Price to sales forward of Moolec Science SA – NASDAQ:MLECW - TradingView
Enterprise value to revenue forward of Moolec Science SA – NASDAQ:MLECW - TradingView
Price to book forward of Moolec Science SA – NASDAQ:MLECW - TradingView
Enterprise value to EBITDA forward of Moolec Science SA – NASDAQ:MLECW - TradingView
Moolec Science SA Warrant (MLECW) Inches Higher Amid Tight Range TradingOption Strike Build - po-news-eg.net
Moolec Science Company Profile & Introduction - Moomoo
Moolec Science SA Warrant (MLECW) Stuck at $0.02 as Trading Activity Remains MinimalRegression Channel - dars.gov.et
MLEC Q2 2025 Earnings: Narrower Net Loss Beats Estimates as Pre-Revenue Company Advances ScienceEarnings Growth Analysis - dars.gov.et
Moolec Science (MLEC) Surges Over 6%: Potential Breakout or Short-Term Rally?Technical Analysis - dars.gov.et
MLEC Q2 2025 Earnings: EPS Beat Estimates Despite No RevenueProfit Warning Alert - dars.gov.et
Enterprise value to EBITDA forward of Moolec Science SA – NASDAQ:MLEC - TradingView
Price to book forward of Moolec Science SA – NASDAQ:MLEC - TradingView
Price to sales forward of Moolec Science SA – NASDAQ:MLEC - TradingView
Price to earnings forward of Moolec Science SA – NASDAQ:MLEC - TradingView
Moolec Science SA Actuals & Estimates (NASDAQ:MLEC) - TradingView
MLEC Q2 2025 Earnings: Narrower-Than-Expected Loss as Pre-Revenue Biotech AdvancesEBITDA Estimate Trend - dars.gov.et
Moolec Science (MLEC) Shares Decline 4.8% as Stock Tests Key Support Near $7.24Mean Reversion Trade - dars.gov.et
Moolec Science SA (MLECW) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Moolec Science (MLEC) Holds Near Support Amid Slight Upward DriftLiquidity Order Flow - dars.gov.et
MLEC Q2 2025 Earnings: Narrower-than-Expected Loss Drives Positive Investor ReactionFree Cash Flow Trends - DonanımHaber
Moolec Science SA (MLECW) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
MOOLEC SCIENCE SA (MLEC) Stock Chart - ChartMill
Moolec Science SA (MLECW) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Moolec Science SA (MLEC) Valuation: PE, PB & Fair Value Analysis - TradingKey
Moolec Science SA (MLECW) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Moolec Science SA (MLECW) Valuation: PE, PB & Fair Value Analysis - TradingKey
Moolec Science SA (MLECW) Institutional Confidence - TradingKey
Moolec Science SA (MLECW) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Moolec Science Sa Stock (MLEC) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.24%
1.78%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):